Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Surgical Sciences (NDS) is delighted to announce that Professor Michael Douek has been elected Vice President of the British Association of Surgical Oncology (BASO) and will take on the role of President in two years’ time.

Michael DouekProfessor Douek is the Rosetrees RCS Director of the Surgical Interventional Trials Unit (SITU) and Professor of Surgical Sciences and Breast Cancer at NDS.

He has been a member of BASO since 1998 and has served on the BASO Council as an Ordinary Member since 2011, as Meetings Secretary from 2015 and was appointed as the Honorary Secretary in 2020. 

His commitment to surgical oncology is longstanding and strong. He was appointed as Senior Lecturer in Surgery at University College London (UCL) in 2003, joining the only surgical oncology firm in the UK under the leadership of Professor Irving Taylor (Past-President of BASO and the European Society of Surgical Oncology). In 2009, he moved to King’s College London where he was Professor of Surgical Oncology. 

Professor Douek graduated from the University of Dundee (Scotland) and trained in surgery in London, Oxford and Cambridge. He obtained his MD from the University of London in 2000. In 2003, he was awarded a prestigious Health Foundation Clinician Scientist grant by the UK Academy of Medical Sciences, funding his joint Senior Lecturer and Consultant post in breast and general surgery at UCL.

Professor Douek is a breast cancer surgeon and surgical oncologist with a special interest in novel techniques for cancer surgery and in breast reconstruction. He was awarded a Hunterian Professorship by the Royal College of Surgeons of England in 2015 and became Research Professor in 2019. He is chief investigator of a number of trials evaluating a magnetic technique for sentinel node biopsy, which he pioneered. These include National Institute of Health Research (NIHR) trials in breast cancer (SentiMAG Multicentre Trial, MagSNOLL Trial) and in melanoma surgery (MELAMAG Multicentre Trial). He setup the first prospective trial of implant breast reconstruction with acellular dermal matrix (ADM), the POBRAD Trial. He is also one of the pioneers of intra-operative radiotherapy (IORT) for breast cancer.

Commenting on his new appointment, Professor Douek said: “I am honoured to help the BASO society and Council meet its challenges and widen its reach."

Similar stories

NDS researchers win poster prizes at CRUK Oxford Centre Annual Symposium

Congratulations to Dr Sandy Figiel and Mr George Adigbli for winning first and second prizes respectively for their poster presentations – out of 53 entries – at the Cancer Research UK (CRUK) Oxford Centre 2023 Annual Symposium on Thursday 16 March.

Mr Gurdeep S. Mannu awarded Cancer Research UK Clinician Scientist Fellowship

Many congratulations to Mr Gurdeep S. Mannu who has been awarded a five-year Cancer Research UK Clinician Scientist Fellowship.

Sheraz Markar awarded Associate Professor title

We are very pleased to announce that Sheraz Markar has been awarded the title of Associate Professor by the University of Oxford.

Blog posts

Marathon challenge for Prostate Cancer UK

Runners of all abilities started 2023 by challenging themselves to run 26.2 miles across January to fundraise for Prostate Cancer UK as part of the charity’s Run the Month: Marathon Edition.

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.